ST. HELIER, Jersey (AP) — ST. HELIER, Jersey (AP) — NovoCure Ltd. (NVCR) on Thursday reported a loss of $47.1 million in its fourth quarter.
The St. Helier, Jersey-based company said it had a loss of 45 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.
The oncology drug developer posted revenue of $133.8 million in the period.
For the year, the company reported a loss of $207 million, or $1.95 per share. Revenue was reported as $509.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR